LONDON--(BUSINESS WIRE)--Technavio has been monitoring the neuroscience antibodies and assays market and it is poised to grow by USD 1.36 bn during 2020-2024, progressing at a CAGR of 8% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

Technological advances has been instrumental in driving the growth of the market. However, high development cost of neuroscience antibodies might hamper market growth. Request a free sample report

Neuroscience antibodies and assays market 2020-2024: Segmentation

Neuroscience antibodies and assays market is segmented as below:

product

Geographic segmentation

To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR40305

Neuroscience antibodies and assays market 2020-2024: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our neuroscience antibodies and assays market report covers the following areas:

This study identifies advances in neuroscience instruments as one of the prime reasons driving the neuroscience antibodies and assays market growth during the next few years.

Neuroscience antibodies and assays market 2020-2024: Vendor Analysis

We provide a detailed analysis of around 25 vendors operating in the neuroscience antibodies and assays market, including some of the vendors such as Abcam Plc, Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche Ltd., GenScript Biotech Corp., Merck KGaA, Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., Tecan Group Ltd. and Thermo Fisher Scientific Inc. Backed with competitive intelligence and benchmarking, our research reports on the neuroscience antibodies and assays market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

Neuroscience antibodies and assays market 2020-2024: Key Highlights

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Original post:
Neuroscience Antibodies and Assays Market 2020-2024 | Technological Advances to Boost Growth | Technavio - Business Wire